uMedical
Medicines
Substances
Companies
Statistics
Menu
All medicines
Litak
Authorised
Human
Details
EMA number
EMEA/H/C/000504
ATC code
L01BB04
Authorisation
14 April 2004
Revision
8
EMA page
Therapeutic indication
Litak is indicated for the treatment of hairy-cell leukaemia.
MeSH:
Leukemia, Hairy Cell
Group:
Antineoplastic agents
Active substances
cladribine
Marketing Authorisation Holder
Lipomed GmbH
MAH
Timeline
Filter by authority:
EMA
Litak authorised
14 Apr 2004
authorised
regulatory
Litak | uMedical